Potential for proteinase-3 to contribute to pro-TNF-α cleavage in inflammatory lung disease

L. Armstrong, K. M. Uppington, A. B. Millar (Bristol, United Kingdom)

Source: Annual Congress 2004 - Pulmonary fibrosis - new insights
Session: Pulmonary fibrosis - new insights
Session type: Oral Presentation
Number: 3022
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Armstrong, K. M. Uppington, A. B. Millar (Bristol, United Kingdom). Potential for proteinase-3 to contribute to pro-TNF-α cleavage in inflammatory lung disease. Eur Respir J 2004; 24: Suppl. 48, 3022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022


Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009


Predictive role of neutrophil elastase in the follow-up of patients with interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy
Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021
Year: 2022



Targeting TNF-alpha in inflammatory lung diseases
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005


A?-Val360: a marker of neutrophil elastase and COPD disease activity
Source: Eur Respir J 2013; 41: 31-38
Year: 2013



The role of matrix metalloproteinases in cystic fibrosis lung disease
Source: Eur Respir J 2011; 38: 721-727
Year: 2011



Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Matrikines in lung inflammation
Source: ERS Lung Science Conference 2018
Year: 2018

Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis
Source: Eur Respir J 2015; 46: 384-394
Year: 2015



Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease.
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021

Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 459s
Year: 2003

Procoagulant activity and signalling in fibroproliferative lung disease
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

Role of IL23 in the development of fibrotic interstitial lung disease
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019